Pyxis Oncology (PYXS)
(Real Time Quote from BATS)
$3.59 USD
-0.02 (-0.55%)
Updated Sep 18, 2024 11:46 AM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Price, Consensus and EPS Surprise
PYXS 3.59 -0.02(-0.55%)
Will PYXS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PYXS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PYXS
Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops Revenue Estimates
Does Pyxis Oncology (PYXS) Have the Potential to Rally 61.29% as Wall Street Analysts Expect?
PYXS: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Pyxis Oncology (PYXS) Rating Upgrade to Buy
Down -15.56% in 4 Weeks, Here's Why You Should You Buy the Dip in Pyxis Oncology, Inc. (PYXS)
Pyxis Oncology, Inc. (PYXS) Upgraded to Strong Buy: What Does It Mean for the Stock?
Other News for PYXS
Moment Of Truth Approaches For Pyxis Oncology
Pyxis Oncology to Participate in Two Upcoming Investor Conferences
Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Spruce Biosciences (SPRB) and Envista Holdings (NVST)
3 Best Stocks to Buy Now, 8/19/2024, According to Top Analysts
Analysts Offer Insights on Healthcare Companies: Gryphon Digital Mining (GRYP) and Pyxis Oncology (PYXS)